Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

106.43
Delayed Data
As of May 27
 +0.65 / +0.61%
Today’s Change
92.98
Today|||52-Week Range
140.72
-11.13%
Year-to-Date
3 Biotech Stocks to Buy in June
May 27 / MotleyFool.com - Paid Partner Content
Today's Trades
May 24 / TheStreet.com - Paid Partner Content
Medivation Fires Back Following Sanofi's Board Proposal
May 27 / TheStreet.com - Paid Partner Content
Is Biotech About to Go from Goat to Hero?
May 24 / TheStreet.com - Paid Partner Content
Interested in Medivation? Take a Number!
May 27 / MotleyFool.com - Paid Partner Content
Pfizer's Buyout of Anacor Pharmaceuticals for $5.2 Billion Is a Bad Move -- Here's Wh...
May 24 / MotleyFool.com - Paid Partner Content
Gilead and Celgene Among Biotechnology Stocks to Buy
May 26 / GuruFocus News - Paid Partner Content
The Best Buys in Biopharma Today
May 24 / MotleyFool.com - Paid Partner Content
If You Like Watching Paint Dry, Today's Your Day!
May 26 / TheStreet.com - Paid Partner Content
How George Soros Invests in Biotech
May 18 / MotleyFool.com - Paid Partner Content
Better Buy: Juno Therapeutics vs. bluebird bio
May 25 / MotleyFool.com - Paid Partner Content
Agios Strikes Metabolic Immuno-Oncology Deal with Celgene
May 18 / Zacks.com - Paid Partner Content
Adding to a Quintet of Longs
May 25 / TheStreet.com - Paid Partner Content
5 Top Biotech Stocks to Buy on Sale
May 17 / MotleyFool.com - Paid Partner Content
The Single Best Stock to Own Today
May 24 / MotleyFool.com - Paid Partner Content